Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Tissue distribution of SVT-40776 indicates a good safety profile

Sep. 29, 2005

AVE-7688 reduces renal fibrosis in COL4A3-/- mice

Sep. 26, 2005

Tachykinin antagonists prepared and tested at Takeda

Sep. 22, 2005

Calcium-sensing receptor (CaSR) validated as a target for bladder dysfunction

Sep. 16, 2005

BXL-628 demonstrates efficacy in experimental autoimmune prostatitis

Sep. 14, 2005

Sanctura XR enters phase III program for overactive bladder

Sep. 13, 2005

Update on darifenacin in overactive bladder

Sep. 12, 2005

Anturol begins phase II study for overactive bladder syndrome

Sep. 12, 2005

Webcasts from ICS Annual Meeting now available

Sep. 8, 2005

A phase II study supports the use of fesoterodine in overactive bladder

Sep. 8, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...